These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
234 related items for PubMed ID: 9124503
1. Activation of the ubiquitin pathway in rat skeletal muscle by catabolic doses of glucocorticoids. Auclair D, Garrel DR, Chaouki Zerouala A, Ferland LH. Am J Physiol; 1997 Mar; 272(3 Pt 1):C1007-16. PubMed ID: 9124503 [Abstract] [Full Text] [Related]
2. Increase in levels of polyubiquitin and proteasome mRNA in skeletal muscle during starvation and denervation atrophy. Medina R, Wing SS, Goldberg AL. Biochem J; 1995 May 01; 307 ( Pt 3)(Pt 3):631-7. PubMed ID: 7741690 [Abstract] [Full Text] [Related]
3. The balance between glucocorticoids and insulin regulates muscle proteolysis via the ubiquitin-proteasome pathway. Bailey JL, Wang X, Price SR. Miner Electrolyte Metab; 1999 May 01; 25(4-6):220-3. PubMed ID: 10681643 [Abstract] [Full Text] [Related]
4. Role of ubiquitin-proteasome pathway in skeletal muscle wasting in rats with endotoxemia. Chai J, Wu Y, Sheng ZZ. Crit Care Med; 2003 Jun 01; 31(6):1802-7. PubMed ID: 12794423 [Abstract] [Full Text] [Related]
5. Activation of the ATP-ubiquitin-proteasome pathway in skeletal muscle of cachectic rats bearing a hepatoma. Baracos VE, DeVivo C, Hoyle DH, Goldberg AL. Am J Physiol; 1995 May 01; 268(5 Pt 1):E996-1006. PubMed ID: 7539218 [Abstract] [Full Text] [Related]
6. Muscle wasting in a rat model of long-lasting sepsis results from the activation of lysosomal, Ca2+ -activated, and ubiquitin-proteasome proteolytic pathways. Voisin L, Breuillé D, Combaret L, Pouyet C, Taillandier D, Aurousseau E, Obled C, Attaix D. J Clin Invest; 1996 Apr 01; 97(7):1610-7. PubMed ID: 8601625 [Abstract] [Full Text] [Related]
7. Evaluation of signals activating ubiquitin-proteasome proteolysis in a model of muscle wasting. Mitch WE, Bailey JL, Wang X, Jurkovitz C, Newby D, Price SR. Am J Physiol; 1999 May 01; 276(5):C1132-8. PubMed ID: 10329962 [Abstract] [Full Text] [Related]
8. The ubiquitin-proteasome proteolytic pathway in heart vs skeletal muscle: effects of acute diabetes. Liu Z, Miers WR, Wei L, Barrett EJ. Biochem Biophys Res Commun; 2000 Oct 05; 276(3):1255-60. PubMed ID: 11027619 [Abstract] [Full Text] [Related]
9. Dantrolene downregulates the gene expression and activity of the ubiquitin-proteasome proteolytic pathway in septic skeletal muscle. Wray CJ, Sun X, Gang GI, Hasselgren PO. J Surg Res; 2002 May 15; 104(2):82-7. PubMed ID: 12020124 [Abstract] [Full Text] [Related]
10. Stimulation of myofibrillar protein degradation and expression of mRNA encoding the ubiquitin-proteasome system in C(2)C(12) myotubes by dexamethasone: effect of the proteasome inhibitor MG-132. Thompson MG, Thom A, Partridge K, Garden K, Campbell GP, Calder G, Palmer RM. J Cell Physiol; 1999 Dec 15; 181(3):455-61. PubMed ID: 10528231 [Abstract] [Full Text] [Related]
11. Contribution of the ubiquitin-proteasome pathway to overall muscle proteolysis in hypercatabolic patients. Biolo G, Bosutti A, Iscra F, Toigo G, Gullo A, Guarnieri G. Metabolism; 2000 Jun 15; 49(6):689-91. PubMed ID: 10877190 [Abstract] [Full Text] [Related]
12. The relationship between skeletal muscle proteolysis and ubiquitin-proteasome proteolytic pathway in burned rats. Chai J, Wu Y, Sheng Z. Burns; 2002 Sep 15; 28(6):527-33. PubMed ID: 12220909 [Abstract] [Full Text] [Related]
13. Glucocorticoids regulate mRNA levels for subunits of the 19 S regulatory complex of the 26 S proteasome in fast-twitch skeletal muscles. Combaret L, Taillandier D, Dardevet D, Béchet D, Rallière C, Claustre A, Grizard J, Attaix D. Biochem J; 2004 Feb 15; 378(Pt 1):239-46. PubMed ID: 14636157 [Abstract] [Full Text] [Related]
14. Acidosis and glucocorticoids concomitantly increase ubiquitin and proteasome subunit mRNAs in rat muscle. Price SR, England BK, Bailey JL, Van Vreede K, Mitch WE. Am J Physiol; 1994 Oct 15; 267(4 Pt 1):C955-60. PubMed ID: 7943291 [Abstract] [Full Text] [Related]
15. What do we really know about the ubiquitin-proteasome pathway in muscle atrophy? Jagoe RT, Goldberg AL. Curr Opin Clin Nutr Metab Care; 2001 May 15; 4(3):183-90. PubMed ID: 11517350 [Abstract] [Full Text] [Related]
16. Insulin-like growth factor I reduces ubiquitin and ubiquitin-conjugating enzyme gene expression but does not inhibit muscle proteolysis in septic rats. Fang CH, Li BG, Sun X, Hasselgren PO. Endocrinology; 2000 Aug 15; 141(8):2743-51. PubMed ID: 10919258 [Abstract] [Full Text] [Related]
17. Skeletal muscle mRNA levels for cathepsin B, but not components of the ubiquitin-proteasome pathway, are increased in patients with lung cancer referred for thoracotomy. Jagoe RT, Redfern CP, Roberts RG, Gibson GJ, Goodship TH. Clin Sci (Lond); 2002 Mar 15; 102(3):353-61. PubMed ID: 11869177 [Abstract] [Full Text] [Related]
18. Sepsis is associated with increased mRNAs of the ubiquitin-proteasome proteolytic pathway in human skeletal muscle. Tiao G, Hobler S, Wang JJ, Meyer TA, Luchette FA, Fischer JE, Hasselgren PO. J Clin Invest; 1997 Jan 15; 99(2):163-8. PubMed ID: 9005983 [Abstract] [Full Text] [Related]
19. Necessary but not sufficient: the role of glucocorticoids in the acidosis-induced increase in levels of mRNAs encoding proteins of the ATP-dependent proteolytic pathway in rat muscle. Price SR, Bailey JL, England BK. Miner Electrolyte Metab; 1996 Jan 15; 22(1-3):72-5. PubMed ID: 8676830 [Abstract] [Full Text] [Related]
20. Regulation of components of the ubiquitin system by insulin-like growth factor I and growth hormone in skeletal muscle of rats made catabolic with dexamethasone. Chrysis D, Underwood LE. Endocrinology; 1999 Dec 15; 140(12):5635-41. PubMed ID: 10579327 [Abstract] [Full Text] [Related] Page: [Next] [New Search]